Elevance Health (MEX:ELV) ROC (Joel Greenblatt) %: % (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:ELV Elevance Health Inc MEX:ELV
70 GF Score
Price MXN6,449.00
GF Value MXN8,489.81
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Elevance Health ROC (Joel Greenblatt) %?

Elevance Health MEX:ELV -9.73% 70 ROC (Joel Greenblatt) % is % as of Jun. 2026. GuruFocus rates MEX:ELV with a GF Score™ of 70/100 and a GF Value™ of MXN8,489.81 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 15 Healthcare Plans companies, Elevance Health ranks worse than 6666660% on this metric.

ROC (Joel Greenblatt) % does not apply to banks and insurance companies.

MEX:ELV
70GF Score
Elevance Health Inc MEX:ELV
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a ROC (Joel Greenblatt) % of % mean?
Elevance Health (MEX:ELV) has a ROC (Joel Greenblatt) % of % as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Elevance Health and its competitors. According to the industry distribution chart, Elevance Health ranks #999999 out of 15 companies in the Healthcare Plans industry.
Is Elevance Health's ROC (Joel Greenblatt) % too high?
Elevance Health's current ROC (Joel Greenblatt) % is %. Based on the distribution chart, Elevance Health ranks #999999 out of 15 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Elevance Health has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's ROC (Joel Greenblatt) % compare to CI and HUM?
According to the Healthcare Plans industry distribution chart, Elevance Health ranks #999999 out of 15 companies for ROC (Joel Greenblatt) %. This places Elevance Health in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 88.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Plans company?
The median ROC (Joel Greenblatt) % among Healthcare Plans companies is 88.08, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Elevance Health and its competitors. For the Healthcare Plans industry, the median ROC (Joel Greenblatt) % is 88.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Elevance Health's current ROC (Joel Greenblatt) % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (MEX:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN8,489.81, compared to a current price of MXN6,449.00 — trading 24% below its estimated fair value. The current ROC (Joel Greenblatt) % is %. Elevance Health's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Elevance Health (MEX:ELV), the current ROC (Joel Greenblatt) % is % as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elevance Health (MEX:ELV) Overvalued in 2026?

Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued. The current stock price of MXN6,449.00 is trading 24% below its estimated GF Value™ of MXN8,489.81. GuruFocus considers Elevance Health to be Modestly Undervalued.

Key valuation signals for MEX:ELV:

  • ROC (Joel Greenblatt) %: %
  • GF Value™: MXN8,489.81 vs. price of MXN6,449.00 (24% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the MEX:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elevance Health Business Description

Address 220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
70GF Score

Get the complete analysis for MEX:ELV

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN6,449.00
Price
MXN8,489.81
GF Value